Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vitamin D Deficiency 4Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Renal Insufficiency, Chronic 1Myelodysplastic Syndromes 1Multiple Sclerosis, Relapsing-Remitting 1Hepatitis B, Chronic 1Hepatitis B 1Hematologic Diseases 1Cardiovascular Diseases 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Bone Diseases, Metabolic 1Anemia, Aplastic 1Anemia 1

Interventions

Sorafenib 9gadolinium ethoxybenzyl DTPA 4Hepatectomy 4lenvatinib 3entecavir 3Sufentanil 3Ribavirin 3Propranolol 3Lamivudine 3sofosbuvir-velpatasvir drug combination 2peginterferon alfa-2a 2gadoterate meglumine 2atezolizumab 2Thrombectomy 2Tenofovir 2Sevoflurane 2Radiofrequency Ablation 2Laparoscopy 2Esketamine 2Chemoembolization, Therapeutic 2Bevacizumab 2xihuang 1stronger neominophagen C 1ledipasvir 1huaier 1halofantrine 1gadoteridol 1gadodiamide 1gadobutrol 1gadobenic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Hepatocellular × Cholecalciferol × Clear all
NCT02779465 2016-05-20

VDHCC

Third Affiliated Hospital, Sun Yat-Sen University

Phase 4 Not yet recruiting
1,500 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡